
Dorsomorphin dihydrochloride
CAS No. 1219168-18-9
Dorsomorphin dihydrochloride ( BML-275 dihydrochloride | Compound C dihydrochloride )
产品货号. M10824 CAS No. 1219168-18-9
Dorsomorphin(BML-275,化合物 C)是一种有效的、选择性的、可逆的 AMPK 抑制剂,Ki 为 109 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥381 | 有现货 |
![]() ![]() |
10MG | ¥518 | 有现货 |
![]() ![]() |
25MG | ¥1110 | 有现货 |
![]() ![]() |
50MG | ¥2001 | 有现货 |
![]() ![]() |
100MG | ¥3621 | 有现货 |
![]() ![]() |
500MG | ¥7995 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Dorsomorphin dihydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Dorsomorphin(BML-275,化合物 C)是一种有效的、选择性的、可逆的 AMPK 抑制剂,Ki 为 109 nM。
-
产品描述Dorsomorphin (BML-275, Compound C) is a potent, selective and reversible AMPK inhibitor with Ki of 109 nM, shows no no significant activity on ZAPK, SYK, PKCθ, PKA and JAK3; inhibits AMPK activation induced by AICAR and Metformin, also inhibits bone morphogenetic protein (BMP) type I receptors (ALK2, ALK3 and ALK6); promotes cardiomyogenesis in mouse embryonic stem cells (ESCs) in vitro, induces autophagy in cancer cell lines via a mechanism independent of AMPK inhibition.(In Vitro):Dorsomorphin (compound C) (0-10 μM, 18 h) suppresses 2DG-induced GRP78 promoter activity in human fibrosarcoma HT1080 cells in a dose-dependent manner but has little effect on tunicamycin-induced GRP78 promoter activity. Dorsomorphin (compound C) C also suppresses GRP78 promoter activity induced by glucose withdrawal. Dorsomorphin (compound C) has no effect on 2DG-induced PERK activation and reduces the both basal and 2DG-induced AMPK phosphorylation levels in HT1080 cells.(In Vivo):Dorsomorphin (compound C; 10 mg/kg, intravenously once) treatment leads to a 60% increase in total serum iron concentrations, reduces basal levels of hepcidin expression and increasing serum iron concentrations in adult mice.Dorsomorphin (compound C; 0.2 mg/kg, i.v., 30 min before LPS injection) reduces ICAM-1 and VCAM-1 expression in LPS-injected rat aorta.Dorsomorphin (compound C; 25 mg/kg; i.p. injection, in male BALB/c mice) treatment before lipopolysaccharide (LPS) injection significantly reduces lethality in contrast to animals treated with LPS challenge only.
-
体外实验——
-
体内实验——
-
同义词BML-275 dihydrochloride | Compound C dihydrochloride
-
通路Membrane Transporter/Ion Channel
-
靶点AMPK
-
受体AMPK
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1219168-18-9
-
分子量472.4
-
分子式C24H27Cl2N5O
-
纯度>98% (HPLC)
-
溶解度H2O: ≥ 48 mg/mL; DMSO: 5.2 mg/mL (Need ultrasonic)
-
SMILESCl.Cl.C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1
-
化学全称Pyrazolo[1,5-a]pyrimidine, 6-[4-[2-(1-piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)-, hydrochloride (1:2)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Yu PB, et al. Nat Chem Biol. 2008 Jan;4(1):33-41.
2. Vucicevic L, et al. Autophagy. 2011 Jan;7(1):40-50.
3. Diekmann U, et al. Stem Cells Dev. 2015 Jan 15;24(2):190-204.
4. Zhou G, et al. J Clin Invest. 2001 Oct;108(8):1167-74.
产品手册




关联产品
-
Cimiracemoside C
Cimiracemoside C 是升麻的活性成分。它激活 AMPK,具有抗糖尿病的潜在活性。
-
ASP4132
ASP4132 是一种口服活性 AMPK 激活剂 (EC50 : 18 nM),具有抗癌活性。
-
Kudinoside D
Kudinoside D 通过 AMPK 信号通路调节脂肪形成转录因子来发挥抗脂肪形成作用。